Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6790 (MIR6790, hsa-mir-6790) is classified as a microRNA, which are small, non-coding RNA molecules (typically 21–23 nucleotides) involved in post-transcriptional regulation of gene expression by binding to target messenger RNAs (mRNAs) and inhibiting their translation or promoting their degradation[1]. MicroRNAs are crucial regulators in many cellular processes, including differentiation, proliferation, and apoptosis[1][2]. However, there is currently no specific, functionally validated information on the role, targets, or disease links of MIR6790 in humans in major scientific literature or databases. It is possible that MIR6790 has been predicted computationally or annotated in sequence databases (e.g., miRBase), but its biological relevance, target genes, and involvement in disease remain undefined in peer-reviewed research to date.
null (no drugs known to target MIR6790; mechanisms of RNA interference or miRNA-mRNA binding apply generally to microRNAs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6790 (MIR6790).